UNSPSC 51191529: Amanozine

This classification denotes a diuretic with the molecular formula C9H9N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X43W7JDA8L, chemically known as 1,3,5-triazine-2,4-diamine, n-phenyl-, monohydrochloride but generally known as amanozine, which bears US NIH Compound Identifier 10832. Amanozine most often comes in base and hydrochloride forms. European Medicines Agency schedules Amanozine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05388MIG.

UNSPSC 51191529 Amanozine is a Commodity-tier code that in recent state and local solicitations covers chemical treatment products and related services for municipal and institutional water, wastewater, and healthcare delivery operations. The three most recent opportunities show state and local governments buying sodium bisulfite for water pollution control facilities, parenteral nutrition and intravenous solutions for correctional healthcare, and specialized valve components with repair and maintenance services for wastewater compliance — a narrow and specialized scope driven by regulatory requirements and facility-specific technical standards rather than general-purpose industrial chemicals. Issuing bodies include municipal utilities (the City of Meriden, Connecticut), county government (Broward County, Florida), and state departments (Washington State Department of Corrections), with the solicitations emphasizing compliance documentation, technical capability certification, and service availability as key qualification criteria alongside commodity supply.

Recent activity concentrates in Florida, Washington, and Connecticut. The Broward County, Florida RFI for DeZurik/APCO valves, parts, and repair services (RFI BLD6232026F23, responses due September 29, 2026) is assessing whether multiple vendors can supply electric-actuated valves compatible with SCADA systems for wastewater treatment compliance. The Washington State Department of Corrections RFQ for parenteral products, services, and equipment (RFQQK13020, bids due October 7, 2026) seeks intravenous nutrition and solution suppliers serving eight correctional facilities across three regions, with DOC encouraging participation from small, minority-owned, women-owned, and veteran-owned businesses and anticipating awards to up to three bidders per region under a contract term through June 30, 2030. The City of Meriden, Connecticut IFB for sodium bisulfite (B027-15, due July 29, 2026) addresses ongoing chemical supply for municipal water pollution control operations.